No biomarker	Cervical Cancer	No biomarker	Cervical Cancer	AGEN2034 + UGN-301 Sensitive: B - Late Trials AGEN2034 + UGN-301 Sensitive : B	AGEN2034 + UGN-301 Sensitive: B - Late Trials AGEN2034 + UGN-301 Sensitive : B
PD-L1 expression	Cervical Cancer	PD-L1 expression	Cervical Cancer	AGEN2034 + UGN-301 Sensitive: C3 – Early Trials AGEN2034 + UGN-301 Sensitive : C3	AGEN2034 + UGN-301 Sensitive: C3 – Early Trials AGEN2034 + UGN-301 Sensitive : C3

zalifrelimab (UGN-301)

Associations
(2)